- Capital Cube•12 days ago
Categories: Yahoo Finance Get free summary analysis MusclePharm Corp. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of MusclePharm Corp. – GNC Holdings, Inc. Class A, Mylan N.V. and Bristol-Myers Squibb Company (GNC-US, MYL-US and BMY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)
- PR Newswire•19 days ago
DENVER, Aug. 9, 2016 /PRNewswire/ -- MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, ...
- PR Newswire•3 months ago
DENVER, May 26, 2016 /PRNewswire/ -- MusclePharm Corporation (MSLP) ("MusclePharm" or the "Company"), a scientifically-driven, performance lifestyle sports nutrition company, announced a reduction of more than $45 million in future commitments to date as part the Company's ongoing restructuring program. The Company has exited a number of sponsorship and endorsement agreements resulting in an overall reduction of approximately $39.5 million in future contractual commitments and an additional $6 million of annualized headcount reduction. In the most recent reduction, the Company entered into an amicable Settlement Agreement with ETW Corp. which places MusclePharm in a stronger financial position going forward.
Muscle Pharm Corp. (MSLP)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||2.25 - 2.34|
|52wk Range||1.95 - 3.20|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.65|
|Avg Vol (3m)||13,673|
|Dividend & Yield||N/A (N/A)|